Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Matthews, S. C.
* Articles by Dimsdale, J. E.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Matthews, S. C.
* Articles by Dimsdale, J. E.
Related Collections
* Syndromes Secondary to General Medical Disorders
Psychosomatics 45:281-286, August 2004
© 2004 The Academy of Psychosomatic Medicine


Review

Contribution of Functional Neuroimaging to Understanding Neuropsychiatric Side Effects of Interferon in Hepatitis C

Scott C. Matthews, M.D., Martin P. Paulus, M.D., and Joel E. Dimsdale, M.D.

Received Nov. 26, 2003; accepted Jan. 26, 2003. From the Department of Psychiatry, University of California, San Diego. Address reprint requests to Dr. Matthews, San Diego VA Hospital, 3350 La Jolla Village Dr., Mail Code 116-A, La Jolla, CA 92161; scmatthews{at}ucsd.edu (e-mail).

Patients with hepatitis C who are treated with interferon may develop neuropsychiatric symptoms, including fatigue and depression. The authors discuss the potential use of functional neuroimaging in the identification and treatment of these patients. The authors provide an overview of functional neuroimaging studies of fatigue and depressive symptoms in various medical and psychiatric conditions and suggest future directions for research that may increase understanding of the specific neural substrates of neuropsychiatric side effects associated with hepatitis C and interferon treatment. This knowledge may help consultation-liaison psychiatrists identify patients at high risk for developing side effects related to hepatitis C and interferon, which would allow for implementation of validated strategies for prophylactic treatment of these patients.







Get information about faster international access.

Privacy Policy

Copyright © 2004 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org